Significance of Programmed Death Ligand 1 (PD-L1) Immunohistochemical Expression in Colorectal Cancer

被引：0
|
作者：
Lisha Wang
Fei Ren
Qifeng Wang
Lee Ann Baldridge
M. Francesca Monn
Kurt W. Fisher
Weiqi Sheng
Xiaoyan Zhou
Xiang Du
Liang Cheng
机构：
[1] Fudan University Shanghai Cancer Center,Department of Pathology
[2] Fudan University,Department of Oncology, Shanghai Medical College
[3] University of Michigan,Michigan Center for Translational Pathology
[4] Indiana University School of Medicine,Department of Pathology and Laboratory Medicine
来源：
Molecular Diagnosis & Therapy | 2016年 / 20卷
关键词：
Colorectal Cancer Patient; Immune Checkpoint; Multiple Cancer Type; Patient Clinical Outcome; Immunosuppressive Tumor Microenvironment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：175 / 181
页数：6
相关论文
共 50 条
  • [21] PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN TYPE 2 ENDOMETRIAL CANCER
    Gulec, U. Kucukgoz
    Bagir, E.
    Paydas, S.
    Seydaoglu, G.
    Guzel, A. B.
    Vardar, M. A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 220 - 220
  • [22] Clinical and pathological significance of programmed cell death 1 (PD-1)/programmed cell death ligand 1 (PD-L1) expression in high grade serous ovarian cancer
    Ba, Yilmaz
    Koc, Nermin
    Helvac, Kaan
    Kocak, Cem
    Akdeniz, Rasit
    Sahin, Havva Hande Keser
    TRANSLATIONAL ONCOLOGY, 2021, 14 (02):
  • [23] Expression and prognostic significance of programmed death-ligand 1 (PD-L1) in Merkel cell carcinoma
    Richter, Igor
    Jirasek, Tomas
    Cermakova, Eva
    Bartos, Jiri
    Buchler, Tomas
    Dvorak, Josef
    JOURNAL OF BUON, 2019, 24 (05): : 2155 - 2160
  • [24] Inhibition of programmed death ligand 1 (PD-L1) expression in breast cancer cells by sesamin
    Kongtawelert, Prachya
    Wudtiwai, Benjawan
    Shwe, Thuzar Hla
    Pothacharoen, Peraphan
    Phitak, Thanyaluck
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 86
  • [25] Expression of programmed cell death protein 1 (PD-1) and its ligand PD-L1 in colorectal cancer: Relationship with sidedness and prognosis
    Berntsson, Jonna
    Eberhard, Jakob
    Nodin, Bjorn
    Leandersson, Karin
    Larsson, Anna H.
    Jirstrom, Karin
    ONCOIMMUNOLOGY, 2018, 7 (08):
  • [26] Is Programmed Death Ligand 1(PD-L1) Expression in Vulvar Cancer Prognostic for Locoregional Control?
    Elgohari, B.
    Patwardhan, P. P.
    Abdelhakiem, M. K.
    Bhargava, R.
    Sukumvanich, P.
    Courtney-Brooks, M.
    Boisen, M. M.
    Berger, J. L.
    Taylor, S.
    Olawaiye, A.
    Lesnock, J.
    Edwards, R. P.
    Beriwal, S.
    Soong, T. R.
    Vargo, J. A. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E511 - E511
  • [27] Expression of programmed death ligand 1 (PD-L1) is associated with metastasis and differentiation in gastric cancer
    He, Peng-xing
    Ma, Zhi-lu
    Han, Huan
    Zhang, Xu-yang
    Niu, Sheng-hui
    Du, Lin-na
    Zheng, Yi-chao
    Liu, Hong-min
    LIFE SCIENCES, 2020, 242
  • [28] PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN UTERINE CARCINOSARCOMAS
    Gulec, U. Kucukgoz
    Bagir, E.
    Paydas, S.
    Seydaoglu, G.
    Guzel, A. B.
    Vardar, M. A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 219 - 219
  • [29] PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN UTERINE CARCINOSARCOMAS
    Gulec, U. Kucukgoz
    Bagir, E.
    Paydas, S.
    Seydaoglu, G.
    Guzel, A. B.
    Vardar, M. A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1125 - 1125
  • [30] Programmed death-ligand 1 (PD-L1) expression in pheochromocytoma.
    Hashimoto, Yasuhiro
    Yamamoto, Hayato
    Hatakeyama, Shingo
    Yoneyama, Takahiro
    Ohyama, Chikara
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
12345